Literature DB >> 32044112

RelB suppresses type I Interferon signaling in dendritic cells.

Irene Saha1, Hemant Jaiswal1, Richa Mishra2, Hendrik J Nel3, Jaring Schreuder4, Monika Kaushik1, Kuldeep Singh Chauhan1, Bhupendra Singh Rawat1, Ranjeny Thomas3, Shalin Naik4, Himanshu Kumar2, Prafullakumar Tailor5.   

Abstract

Type I Interferon (IFN) signaling plays a critical role in dendritic cell (DC) development and functions. Inhibition of hyper type I IFN signaling promotes cDC2 subtype development. Relb is essential to development of cDC2 subtype and here we analyzed its effect on type I IFN signaling in DCs. We show that Relb suppresses the homeostatic type I IFN signaling in cDC2 cultures. TLR stimulation of FL-DCs led to RelB induction coinciding with fall in IFN signatures; conforming with the observation Relb expression reduced TLR stimulated IFN induction along with decrease in ISGs. Towards understanding mechanism, we show that effects of RelB are mediated by increased levels of IκBα. We demonstrate that RelB dampened antiviral responses by lowering ISG levels and the defect in cDC2 development in RelB null mice can be rescued in Ifnar1-/- background. Overall, we propose a novel role of RelB as a negative regulator of the type I IFN signaling pathway; fine tuning development of cDC2 subtype.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cell differentiation; Interferon stimulated genes (ISGs); NF-κB signaling; RelB; Type I Interferon (IFN)

Year:  2020        PMID: 32044112     DOI: 10.1016/j.cellimm.2020.104043

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity.

Authors:  Francesco Borriello; Valentina Poli; Ellen Shrock; Roberto Spreafico; Xin Liu; Novalia Pishesha; Claire Carpenet; Janet Chou; Marco Di Gioia; Marisa E McGrath; Carly A Dillen; Nora A Barrett; Lucrezia Lacanfora; Marcella E Franco; Laura Marongiu; Yoichiro Iwakura; Ferdinando Pucci; Michael D Kruppa; Zuchao Ma; Douglas W Lowman; Harry E Ensley; Etsuro Nanishi; Yoshine Saito; Timothy R O'Meara; Hyuk-Soo Seo; Sirano Dhe-Paganon; David J Dowling; Matthew Frieman; Stephen J Elledge; Ofer Levy; Darrell J Irvine; Hidde L Ploegh; David L Williams; Ivan Zanoni
Journal:  Cell       Date:  2022-02-10       Impact factor: 41.582

2.  Lack of Interferon (IFN) Regulatory Factor 8 Associated with Restricted IFN-γ Response Augmented Japanese Encephalitis Virus Replication in the Mouse Brain.

Authors:  Aarti Tripathi; Bhupendra Singh Rawat; Sankar Addya; Milan Surjit; Prafullakumar Tailor; Sudhanshu Vrati; Arup Banerjee
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

3.  Mutation in Irf8 Gene (Irf8R294C ) Impairs Type I IFN-Mediated Antiviral Immune Response by Murine pDCs.

Authors:  Annesa Das; Kuldeep Singh Chauhan; Himanshu Kumar; Prafullakumar Tailor
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

4.  Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction.

Authors:  Julie Bourseguin; Wen Cheng; Emily Talbot; Liana Hardy; Jenny Lai; Ailsa M Jeffries; Michael A Lodato; Eunjung Alice Lee; Svetlana V Khoronenkova
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.